Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
Q1 2024 vs. Q4 2023
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 18 | 1 | 17 | 0 |
| Shares | 5.63M | 105.0K | 5.63M | +98.3K (+1.8%) |
| Value | $384.0K | $5.25K | $385.1K | +$6.44K (+1.7%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Exos Asset Management LLC | 105,000 | $5.46K | 0.00% |
| Citadel Advisors LLC | 15,873 | $825 | 0.00% |
| UBS Group AG | 133 | $7 | 0.00% |
Sold out (3)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Wolverine Asset Management LLC | 5,229 | $261 |
| Sea Otter Advisors LLC | 4,871 | $244 |
| Bank of Montreal | 12,500 | – |
Not filed for Q1 2024 yet (1)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Exos TFP Holdings LLC | 105,000 | $5.25K |